Radiation-induced hemorrhagic cystitis. (2014 study) Skip to main content
Clinical Study Current opinion in supportive and palliative care 2014 Canadian

Radiation-induced hemorrhagic cystitis.

Alesawi AM, El-Hakim A, Zorn KC, Saad F, Current opinion in supportive and palliative care, 2014

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote a review of how radiation-induced hemorrhagic cystitis (bleeding from the bladder lining) develops, and of the pros and cons of the treatments and prevention steps available.

What They Found

This review of hemorrhagic cystitis found that the condition is uncommon, most often caused by radiation therapy and cyclophosphamide, and treated in many ways, from simple bladder irrigation to cystectomy with urinary diversion. Advances in radiation technology have greatly reduced side-effects such as hemorrhagic cystitis. Higher dose radiation is more often linked with problematic bleeding. The abstract reports that recent attempts to manage it have included hyperbaric oxygen therapy and transurethral coagulation with a Greenlight potassium-titanyl-phosphate laser, but it states that larger cohort studies are still needed. The abstract gives no numbers.

What This Means for Canadian Patients

For people who have had pelvic radiation, the abstract says bladder bleeding can happen, and that it is more often a problem with higher radiation doses. It lists hyperbaric oxygen therapy as one of several recent attempts to manage the condition. It does not report how well it works, which patients it suits, or any treatment protocol, so it gives no basis for choosing one option over another. Anyone with bladder bleeding should talk with their urology or cancer care team.

Canadian Relevance

This study is marked as having a Canadian connection. The abstract itself does not give details of that connection.

Study Limitations

This is a narrative review with no reported patient data, and the abstract says hyperbaric oxygen therapy and the other newer approaches still need investigation in larger cohort studies.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Radiation Injury
Source Pubmed
PubMed ID 25004179
Year Published 2014
Journal Current opinion in supportive and palliative care
MeSH Terms Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystectomy; Cystitis; Electrocoagulation; Hemorrhage; Humans; Hyperbaric Oxygenation; Radiation Injuries; Risk Factors; Therapeutic Irrigation

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology